PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Enzyme Activators
  • Protein Phosphatase 2
  • Proto-Oncogene Proteins p21(ras)

abstract

  • BP2 consolidates the analytical evidence for interchangeability of the 22C3, 28-8, and SP263 assays and lower sensitivity of the SP142 assay for determining tumor proportion score on TCs and demonstrates greater sensitivity of the 73-10 assay compared with that of the other assays.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.jtho.2018.05.013

PubMed ID

  • 29800747

Additional Document Info